Alcolase Raises €1.5 Million to Build Enzyme-Based Remedy for Alcohol Flush
Copenhagen-based biotech startup Alcolase has raised €1.5 million to develop an enzyme-based solution for alcohol flush, a condition linked to alcohol intolerance and ALDH2 deficiency.…
May 18







